Results Could Help Answer Questions About Your Ability to Get or Stay Pregnant
MARLTON, N.J. (Aug. 23, 2016)—Reproductive Medicine Associates of New Jersey (RMANJ), a world-renowned leader in the field of infertility care, will be offering free AMH fertility screening at their newest location in Marlton, New Jersey. This test, which could help provide answers about your ability to get or stay pregnant, will be available free of charge for a limited time through the fall for hopeful parents in the South Jersey and Philadelphia metropolitan area.
AMH (anti-mullerian hormone) is a key indicator of ovarian reserve—a woman’s remaining egg supply—and AMH levels that are too high or too low may suggest fertility problems. Evaluation of AMH, along with FSH (follicle stimulating hormone), estrogen and age, is often the first step to finding answers.
“The AMH test is just one step in predicting a woman’s ability to conceive either naturally or with the assistance of fertility services such as IVF,” said Dr. Jason Franasiak, lead physician at RMANJ’s newest location in Marlton serving the South Jersey and Philadelphia metropolitan area. “In offering this free screening, we hope to provide concrete information that can serve as a starting point for patients to discuss their concerns as they look for more information on their ability to build a family, either now or in the future.”
Dr. Daniel Kaser from RMANJ Marlton added “Knowledge is power. AMH screening takes just a few minutes and can be done on any day of a woman’s cycle via a simple blood test. Patients will receive a follow-up call from a RMANJ healthcare provider with results and recommendations.”
RMANJ will be offering free screening at its Marlton office located in Elmwood Business Park, 737 East Route 70, Building B-101, Marlton, New Jersey 08053, Monday through Friday from 6 a.m. to 2 p.m. Appointments, while not required, are recommended for convenience and can be made by calling the office directly at 856-267-8100.
RMANJ has seen patients from 40 U.S. states and 30 international countries. With IVF delivery rates above 60 percent, nearly 20 percent higher than the national average, RMANJ supports hopeful patients with the widest range of services, including in vitro fertilization (IVF), egg donation, gestational surrogacy, comprehensive chromosome screening (CCS), pre-implantation genetic diagnosis (PGD), fertility preservation services, acupuncture, yoga and patient-to-patient networking.
The experts at RMANJ offer IVF delivery rates of 63.2 percent in women under 35 (n=886) and well above the US average*. Since 1999, they have helped bring nearly 40,000 babies to loving families. RMANJ has 25 physicians and 10 locations in New Jersey: Basking Ridge, Eatontown, Englewood, Freehold, Hamilton, Morristown, Somerset, Springfield, West Orange, and its newest location in Marlton, New Jersey. For more information, please call 973-656-2089 or visit www.rmanj.com.
RMANJ pioneered and successfully implemented a cutting-edge technology known as Select Comprehensive Chromosome Screening (SelectCCS) to more accurately detect healthy embryos that has led to successful pregnancies and ultimately healthy babies. SelectCCS is owned and operated by the Foundation for Embryonic Competence (www.feclabs.org) and offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.
*SART 2014; Cumulative Outcome per Intended Retrieval; Preliminary Chance of Live Birth per Cycle. Please note: A comparison of clinic success rates may not be meaningful because a patient’s medical characteristics, treatment approaches and entrance criteria for assisted reproductive technology (ART) may vary from clinic to clinic. Visit www.sart.org to learn more.